This study reveals that the tumor suppressor RBM10 works with ribosomal proteins and acts to inhibit the oncogenic activity of c-Myc, whereas a lung cancer–derived RMB10 mutant fails to do so; instead, it promotes lung cancer growth. Here, MYC is linked to neoplasm.